Soft Tissue Repair Market by Product (Tissue Patches, Interference Screws, Xenografts, Suture Anchors, Laparoscopic Instruments), Application (Orthopedic, Skin, Dental), End User (Hospitals, Clinics, Ambulatory Surgery Centres) - Global Forecast to 2030
The soft tissue repair market is projected to reach USD 20.5 million by 2030 from USD 15.9 million in 2025, growing at a CAGR of 5.1 % from 2025 to 2030.
The rising demand for soft tissue repair is growing rapidly due to the increasing volume of surgeries and the growing prevalence of severe trauma injuries.
The primary objective of soft tissue repair instruments and consumables is to fortify compromised tissue or surgically address torn or damaged soft tissue structures. The steady market growth in this sector can be attributed to several key factors, including the proliferation of innovative products across various subfields of soft tissue repair, the increasing incidence of sports-related injuries among the youth demographic, and the aging population, which is more prone to orthopedic soft tissue injuries and hernias. Moreover, advancements in healthcare infrastructure, coupled with heightened government investment in health systems and rising disposable incomes, particularly in Latin America and the Asia Pacific regions, are significantly propelling market expansion. However, challenges remain that could hinder progress, such as limited insurance reimbursements, intricate regulatory landscapes, and the high costs associated with surgical interventions.
“By product, the tissue patches/meshes segment accounted for the largest market share in the soft tissue repair market in 2024.”
The tissue patches/meshes segment commanded the largest share in the soft tissue repair market in 2024, primarily due to its extensive applications in hernia repair, pelvic organ prolapse, and various reconstructive procedures that necessitate the reinforcement or replacement of compromised soft tissues. The ascendancy of these products can be attributed to their structural support capabilities, reduced operative time, and improved patient outcomes. The rising adoption of both biologic and synthetic meshes, which exhibit enhanced integration with native tissues and a lower incidence of complications, has further fueled demand. Recent advancements in mesh technology, focusing on the development of lightweight, biocompatible, and absorbable polymers, have significantly bolstered their clinical acceptance and expanded their applications. Furthermore, the increasing prevalence of obesity, coupled with an aging demographic and a growing volume of surgeries requiring tissue reinforcement and reconstruction, contributes to the segment's robust growth. Moreover, the favorable reimbursement landscape for hernia and soft tissue repair procedures in developed markets enhances the adoption of patches and meshes, thereby solidifying their leading role within the product portfolio.
“By application, the skin repair segment held the third-largest market share in the soft tissue repair market in 2024.”
In the context of application types within the soft tissue repair market, skin repair represents the third-largest segment. A key factor influencing this segment is the high prevalence of chronic wounds, which necessitate effective skin repair interventions, such as those for diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The growing incidence of burn injuries and traumatic skin wounds further escalates the demand for advanced wound care and skin grafting solutions. Recent advancements in wound care technologies, including innovations in collagen dressings, growth factor therapies, and bioengineered skin substitutes, have markedly improved treatment efficacy. Moreover, heightened awareness among both patients and healthcare practitioners regarding the critical importance of timely wound management has played a substantial role in this market's expansion. Coupled with the increasing availability of insurance coverage for chronic wound care in many developed nations, these factors collectively contribute to the sustained growth of the skin repair segment within the broader soft tissue repair market.
“By end user, the hospitals & clinics segment had the largest market share in the soft tissue repair market in 2024.”
Hospitals and clinics dominate the market share largely due to their substantial patient throughput, which drives the demand for a wide spectrum of treatments ranging from routine procedures to complex surgical interventions. These institutions are often the primary access points for acute conditions such as trauma, sports-related injuries, and other ailments that require advanced soft tissue repair techniques. Equipped with highly qualified medical personnel and sophisticated infrastructure, hospitals often feature specialized departments—such as sports medicine, general surgery, and orthopedics—that enable comprehensive diagnostic capabilities and surgical interventions. Additionally, larger hospitals and comprehensive care clinics leverage economies of scale, allowing them to procure state-of-the-art surgical products and cutting-edge technologies. Their substantial funding and established relationships with leading medical device manufacturers enhance their ability to adopt and implement innovative solutions in patient care.
“By region, Europe had the second-largest market share in the soft tissue repair market in 2024.”
Europe is in the second leading position in the soft tissue repair market due to a combination of elements. A strong healthcare infrastructure backs the region, which facilitates widespread access to advanced surgical procedures and technologies. There is an unnatural need for soft tissue repair offerings brought about by the convergence of extensive age-related hernias and orthopedic diseases with a growing elderly population. European countries have strong reimbursement systems in place, along with favorable regulatory environments, which collectively encourage the uptake of innovative medical devices. The region is topped up by sustained funding for healthcare research, along with widespread adoption of early surgical techniques and the formation of leading medical device firms. The demand for soft tissue repair products in Europe has gained momentum with the increased awareness of patients and healthcare specialists regarding minimally invasive treatments and improved post-surgical results.
A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
Research Coverage:
The report analyzes the soft tissue repair market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall soft tissue repair market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (increasing geriatric population and obesity rate, rising incidence of sports injuries and trauma cases, growing focus on R&D for technologically advanced soft tissue repair product manufacturing, increasing volume of surgeries) restraints (unfavorable reimbursement scenario, high cost of advanced orthodontic treatment and surgical procedures) opportunities (growing adoption of regenerative medicine and biologics in emerging economies, increasing use of combination materials for enhancing product efficacy), challenges (stringent regulatory framework, shortage of skilled surgeons and specialized facilities)
Market Penetration: The report includes extensive information on products offered by the major players in the global soft tissue repair market. It also includes various segments by product, application, end user, and region.
Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global soft tissue repair market.
Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.
Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global soft tissue repair market.
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global soft tissue repair market.
The rising demand for soft tissue repair is growing rapidly due to the increasing volume of surgeries and the growing prevalence of severe trauma injuries.
The primary objective of soft tissue repair instruments and consumables is to fortify compromised tissue or surgically address torn or damaged soft tissue structures. The steady market growth in this sector can be attributed to several key factors, including the proliferation of innovative products across various subfields of soft tissue repair, the increasing incidence of sports-related injuries among the youth demographic, and the aging population, which is more prone to orthopedic soft tissue injuries and hernias. Moreover, advancements in healthcare infrastructure, coupled with heightened government investment in health systems and rising disposable incomes, particularly in Latin America and the Asia Pacific regions, are significantly propelling market expansion. However, challenges remain that could hinder progress, such as limited insurance reimbursements, intricate regulatory landscapes, and the high costs associated with surgical interventions.
“By product, the tissue patches/meshes segment accounted for the largest market share in the soft tissue repair market in 2024.”
The tissue patches/meshes segment commanded the largest share in the soft tissue repair market in 2024, primarily due to its extensive applications in hernia repair, pelvic organ prolapse, and various reconstructive procedures that necessitate the reinforcement or replacement of compromised soft tissues. The ascendancy of these products can be attributed to their structural support capabilities, reduced operative time, and improved patient outcomes. The rising adoption of both biologic and synthetic meshes, which exhibit enhanced integration with native tissues and a lower incidence of complications, has further fueled demand. Recent advancements in mesh technology, focusing on the development of lightweight, biocompatible, and absorbable polymers, have significantly bolstered their clinical acceptance and expanded their applications. Furthermore, the increasing prevalence of obesity, coupled with an aging demographic and a growing volume of surgeries requiring tissue reinforcement and reconstruction, contributes to the segment's robust growth. Moreover, the favorable reimbursement landscape for hernia and soft tissue repair procedures in developed markets enhances the adoption of patches and meshes, thereby solidifying their leading role within the product portfolio.
“By application, the skin repair segment held the third-largest market share in the soft tissue repair market in 2024.”
In the context of application types within the soft tissue repair market, skin repair represents the third-largest segment. A key factor influencing this segment is the high prevalence of chronic wounds, which necessitate effective skin repair interventions, such as those for diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The growing incidence of burn injuries and traumatic skin wounds further escalates the demand for advanced wound care and skin grafting solutions. Recent advancements in wound care technologies, including innovations in collagen dressings, growth factor therapies, and bioengineered skin substitutes, have markedly improved treatment efficacy. Moreover, heightened awareness among both patients and healthcare practitioners regarding the critical importance of timely wound management has played a substantial role in this market's expansion. Coupled with the increasing availability of insurance coverage for chronic wound care in many developed nations, these factors collectively contribute to the sustained growth of the skin repair segment within the broader soft tissue repair market.
“By end user, the hospitals & clinics segment had the largest market share in the soft tissue repair market in 2024.”
Hospitals and clinics dominate the market share largely due to their substantial patient throughput, which drives the demand for a wide spectrum of treatments ranging from routine procedures to complex surgical interventions. These institutions are often the primary access points for acute conditions such as trauma, sports-related injuries, and other ailments that require advanced soft tissue repair techniques. Equipped with highly qualified medical personnel and sophisticated infrastructure, hospitals often feature specialized departments—such as sports medicine, general surgery, and orthopedics—that enable comprehensive diagnostic capabilities and surgical interventions. Additionally, larger hospitals and comprehensive care clinics leverage economies of scale, allowing them to procure state-of-the-art surgical products and cutting-edge technologies. Their substantial funding and established relationships with leading medical device manufacturers enhance their ability to adopt and implement innovative solutions in patient care.
“By region, Europe had the second-largest market share in the soft tissue repair market in 2024.”
Europe is in the second leading position in the soft tissue repair market due to a combination of elements. A strong healthcare infrastructure backs the region, which facilitates widespread access to advanced surgical procedures and technologies. There is an unnatural need for soft tissue repair offerings brought about by the convergence of extensive age-related hernias and orthopedic diseases with a growing elderly population. European countries have strong reimbursement systems in place, along with favorable regulatory environments, which collectively encourage the uptake of innovative medical devices. The region is topped up by sustained funding for healthcare research, along with widespread adoption of early surgical techniques and the formation of leading medical device firms. The demand for soft tissue repair products in Europe has gained momentum with the increased awareness of patients and healthcare specialists regarding minimally invasive treatments and improved post-surgical results.
A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–20%, Director Level 35%, and Others–45%
- By Region: North America–27%, Europe–25%, Asia Pacific–30%, Others–18%.
Research Coverage:
The report analyzes the soft tissue repair market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall soft tissue repair market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (increasing geriatric population and obesity rate, rising incidence of sports injuries and trauma cases, growing focus on R&D for technologically advanced soft tissue repair product manufacturing, increasing volume of surgeries) restraints (unfavorable reimbursement scenario, high cost of advanced orthodontic treatment and surgical procedures) opportunities (growing adoption of regenerative medicine and biologics in emerging economies, increasing use of combination materials for enhancing product efficacy), challenges (stringent regulatory framework, shortage of skilled surgeons and specialized facilities)
Market Penetration: The report includes extensive information on products offered by the major players in the global soft tissue repair market. It also includes various segments by product, application, end user, and region.
Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global soft tissue repair market.
Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.
Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global soft tissue repair market.
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global soft tissue repair market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.1.2.5 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS
2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
2.2.3 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE AND ADOPTION PATTERN)
2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
2.2.5 VOLUME ESTIMATION
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 RESEARCH LIMITATIONS
2.5.1 SCOPE-RELATED LIMITATIONS
2.5.2 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ANALYSIS
2.7 STUDY ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SOFT TISSUE REPAIR MARKET OVERVIEW
4.2 SOFT TISSUE REPAIR MARKET: REGIONAL MIX
4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2024)
4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing geriatric population and rising prevalence of obesity
5.2.1.2 Increasing occurrence of sports injuries
5.2.1.3 Rise in R&D investments and launch of technologically advanced products
5.2.1.4 High volume of surgeries and advancements in regenerative technologies
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario
5.2.2.2 High cost of soft tissue repair products and surgical procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging economies
5.2.3.2 Rising use of combination materials for enhancing product efficacy
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory framework
5.2.4.2 Requirement of skilled personnel for effective use of soft tissue repair products
5.3 ECOSYSTEM ANALYSIS
5.3.1 ROLE IN ECOSYSTEM
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024
5.4.2 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
5.4.3 AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024
5.5 SUPPLY CHAIN ANALYSIS
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
5.6.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
5.6.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET
5.6.4 LIST OF MAJOR PATENTS
5.7 VALUE CHAIN ANALYSIS
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGIES
5.8.1.1 Stem cell and regenerative therapies
5.8.1.2 Suture anchors and fixation devices
5.8.2 ADJACENT TECHNOLOGIES
5.8.2.1 3D bioprinting and tissue engineering
5.8.2.2 Regenerative medicine and biologics
5.8.3 COMPLEMENTARY TECHNOLOGIES
5.8.3.1 Wound closure and hemostatic devices
5.9 TRADE ANALYSIS
5.9.1 IMPORT DATA FOR HS CODE 300640, 2019–2023
5.9.2 EXPORT DATA FOR HS CODE 300640, 2019–2023
5.10 KEY CONFERENCES & EVENTS, 2025–2026
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY FRAMEWORK
5.11.1.1 North America
5.11.1.1.1 US
5.11.1.1.2 Canada
5.11.1.2 Europe
5.11.1.3 Asia Pacific
5.11.1.3.1 China
5.11.1.3.2 Japan
5.11.1.3.3 India
5.11.1.4 Latin America
5.11.1.4.1 Brazil
5.11.1.4.2 Mexico
5.11.1.5 Middle East
5.11.1.6 Africa
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 INTENSITY OF COMPETITIVE RIVALRY
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 THREAT OF SUBSTITUTES
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.15 CASE STUDY ANALYSIS
5.15.1 TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
5.15.2 TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
5.15.3 HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
5.16 INVESTMENT & FUNDING SCENARIO
5.17 REIMBURSEMENT SCENARIO ANALYSIS
5.18 END-USER EXPECTATIONS
5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON END-USE INDUSTRIES
6 SOFT TISSUE REPAIR MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 TISSUE PATCHES/MESHES
6.2.1 SYNTHETIC MESHES
6.2.1.1 Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth
6.2.2 BIOLOGICAL MESHES
6.2.2.1 Allografts
6.2.2.1.1 Better biocompatibility to fuel adoption in surgeries and organ transplants
6.2.2.2 Xenografts
6.2.2.2.1 Availability in multiple sizes to make xenografts more viable alternative in soft tissue repair procedures
6.2.3 FIXATION PRODUCTS
6.2.3.1 Suture anchors
6.2.3.1.1 Increasing number of soft tissue injuries and growing need for surgeries to augment segment growth
6.2.3.2 Interference screws
6.2.3.2.1 Rise in injuries among geriatric population and availability of biodegradable interference screws to drive segment
6.2.3.3 Other fixation products
6.3 LAPAROSCOPIC INSTRUMENTS
6.3.1 QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET
6.4 OTHER PRODUCTS
7 SOFT TISSUE REPAIR MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 HERNIA REPAIR
7.2.1 RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO FUEL MARKET GROWTH
7.3 SKIN REPAIR
7.3.1 RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH
7.4 ORTHOPEDIC SOFT TISSUE REPAIR
7.4.1 INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH
7.5 DENTAL SOFT TISSUE REPAIR
7.5.1 RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH
7.6 BREAST RECONSTRUCTION
7.6.1 PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH
7.7 DURAL REPAIR
7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET
7.8 VAGINAL SLINGS
7.8.1 INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH
7.9 OTHER APPLICATIONS
8 SOFT TISSUE REPAIR MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & CLINICS
8.2.1 RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES TO DRIVE MARKET
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY TO FUEL MARKET GROWTH
8.4 OTHER END USERS
9 SOFT TISSUE REPAIR MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American soft tissue repair market during forecast period
9.2.3 CANADA
9.2.3.1 High healthcare expenditure and favorable public & private funding to support market growth
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth
9.3.3 FRANCE
9.3.3.1 Well-established healthcare system and high geriatric population to boost market growth
9.3.4 UK
9.3.4.1 Increasing hernia repair and cardiovascular surgeries to stimulate market growth
9.3.5 ITALY
9.3.5.1 Favorable government initiatives and high demand for surgical interventions to support market growth
9.3.6 SPAIN
9.3.6.1 Increasing healthcare budget and rising focus on local medical product manufacturing to drive market
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.2.1 Strong healthcare system and high geriatric population to favor market growth
9.4.3 CHINA
9.4.3.1 Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth
9.4.4 INDIA
9.4.4.1 Greater healthcare awareness and increased government support to aid market growth
9.4.5 AUSTRALIA
9.4.5.1 Increasing government support and rising healthcare expenditure to support market growth
9.4.6 SOUTH KOREA
9.4.6.1 Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Strong public healthcare system and favorable government-led initiatives to aid market growth
9.5.3 MEXICO
9.5.3.1 Increased focus on healthcare modernization and surgical innovation to favor market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.7 GCC COUNTRIES
9.7.1 FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
10.3 REVENUE ANALYSIS, 2020–2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Application footprint
10.5.5.5 End-user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of startups/SMEs
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 R&D EXPENDITURE
10.9 BRAND/PRODUCT COMPARISON
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES
10.10.2 DEALS
10.10.3 EXPANSIONS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 ARTHREX, INC.
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 MnM view
11.1.1.3.1 Right to win
11.1.1.3.2 Strategic choices
11.1.1.3.3 Weaknesses & competitive threats
11.1.2 SMITH & NEPHEW PLC
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches
11.1.2.3.2 Deals
11.1.2.3.3 Expansions
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 JOHNSON & JOHNSON SERVICES, INC.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 BECTON, DICKINSON AND COMPANY (BD)
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 MnM view
11.1.4.3.1 Right to win
11.1.4.3.2 Strategic choices
11.1.4.3.3 Weaknesses & competitive threats
11.1.5 STRYKER
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 MnM view
11.1.5.3.1 Right to win
11.1.5.3.2 Strategic choices
11.1.5.3.3 Weaknesses & competitive threats
11.1.6 MEDTRONIC
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.6.3.2 Expansions
11.1.6.3.3 Other developments
11.1.7 ZIMMER BIOMET
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Deals
11.1.8 INTEGRA LIFESCIENCES CORPORATION
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 ARTIVION, INC.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 ORGANOGENESIS INC.
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 LIFENET HEALTH
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 BAXTER
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.13 TISSUE REGENIX
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.14 CONMED CORPORATION
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.15 MERIL LIFE SCIENCES PVT. LTD.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.16 RTI SURGICAL
11.1.16.1 Business overview
11.1.16.2 Products offered
11.2 OTHER PLAYERS
11.2.1 SAMYANG HOLDINGS CORPORATION
11.2.2 AROA BIOSURGERY LIMITED
11.2.3 ACERA SURGICAL INC.
11.2.4 ORTHOCELL LTD.
11.2.5 ACELL, INC.
11.2.6 BIOCER ENTWICKLUNGS-GMBH
11.2.7 ISTO BIOLOGICS
11.2.8 BETATECH MEDICAL
11.2.9 MIMEDX GROUP, INC.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.1.2.5 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS
2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
2.2.3 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE AND ADOPTION PATTERN)
2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
2.2.5 VOLUME ESTIMATION
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 RESEARCH LIMITATIONS
2.5.1 SCOPE-RELATED LIMITATIONS
2.5.2 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ANALYSIS
2.7 STUDY ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SOFT TISSUE REPAIR MARKET OVERVIEW
4.2 SOFT TISSUE REPAIR MARKET: REGIONAL MIX
4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2024)
4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing geriatric population and rising prevalence of obesity
5.2.1.2 Increasing occurrence of sports injuries
5.2.1.3 Rise in R&D investments and launch of technologically advanced products
5.2.1.4 High volume of surgeries and advancements in regenerative technologies
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario
5.2.2.2 High cost of soft tissue repair products and surgical procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging economies
5.2.3.2 Rising use of combination materials for enhancing product efficacy
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory framework
5.2.4.2 Requirement of skilled personnel for effective use of soft tissue repair products
5.3 ECOSYSTEM ANALYSIS
5.3.1 ROLE IN ECOSYSTEM
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024
5.4.2 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
5.4.3 AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024
5.5 SUPPLY CHAIN ANALYSIS
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
5.6.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
5.6.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET
5.6.4 LIST OF MAJOR PATENTS
5.7 VALUE CHAIN ANALYSIS
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGIES
5.8.1.1 Stem cell and regenerative therapies
5.8.1.2 Suture anchors and fixation devices
5.8.2 ADJACENT TECHNOLOGIES
5.8.2.1 3D bioprinting and tissue engineering
5.8.2.2 Regenerative medicine and biologics
5.8.3 COMPLEMENTARY TECHNOLOGIES
5.8.3.1 Wound closure and hemostatic devices
5.9 TRADE ANALYSIS
5.9.1 IMPORT DATA FOR HS CODE 300640, 2019–2023
5.9.2 EXPORT DATA FOR HS CODE 300640, 2019–2023
5.10 KEY CONFERENCES & EVENTS, 2025–2026
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY FRAMEWORK
5.11.1.1 North America
5.11.1.1.1 US
5.11.1.1.2 Canada
5.11.1.2 Europe
5.11.1.3 Asia Pacific
5.11.1.3.1 China
5.11.1.3.2 Japan
5.11.1.3.3 India
5.11.1.4 Latin America
5.11.1.4.1 Brazil
5.11.1.4.2 Mexico
5.11.1.5 Middle East
5.11.1.6 Africa
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 INTENSITY OF COMPETITIVE RIVALRY
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 THREAT OF SUBSTITUTES
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.15 CASE STUDY ANALYSIS
5.15.1 TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
5.15.2 TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
5.15.3 HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
5.16 INVESTMENT & FUNDING SCENARIO
5.17 REIMBURSEMENT SCENARIO ANALYSIS
5.18 END-USER EXPECTATIONS
5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON END-USE INDUSTRIES
6 SOFT TISSUE REPAIR MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 TISSUE PATCHES/MESHES
6.2.1 SYNTHETIC MESHES
6.2.1.1 Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth
6.2.2 BIOLOGICAL MESHES
6.2.2.1 Allografts
6.2.2.1.1 Better biocompatibility to fuel adoption in surgeries and organ transplants
6.2.2.2 Xenografts
6.2.2.2.1 Availability in multiple sizes to make xenografts more viable alternative in soft tissue repair procedures
6.2.3 FIXATION PRODUCTS
6.2.3.1 Suture anchors
6.2.3.1.1 Increasing number of soft tissue injuries and growing need for surgeries to augment segment growth
6.2.3.2 Interference screws
6.2.3.2.1 Rise in injuries among geriatric population and availability of biodegradable interference screws to drive segment
6.2.3.3 Other fixation products
6.3 LAPAROSCOPIC INSTRUMENTS
6.3.1 QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET
6.4 OTHER PRODUCTS
7 SOFT TISSUE REPAIR MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 HERNIA REPAIR
7.2.1 RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO FUEL MARKET GROWTH
7.3 SKIN REPAIR
7.3.1 RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH
7.4 ORTHOPEDIC SOFT TISSUE REPAIR
7.4.1 INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH
7.5 DENTAL SOFT TISSUE REPAIR
7.5.1 RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH
7.6 BREAST RECONSTRUCTION
7.6.1 PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH
7.7 DURAL REPAIR
7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET
7.8 VAGINAL SLINGS
7.8.1 INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH
7.9 OTHER APPLICATIONS
8 SOFT TISSUE REPAIR MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & CLINICS
8.2.1 RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES TO DRIVE MARKET
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY TO FUEL MARKET GROWTH
8.4 OTHER END USERS
9 SOFT TISSUE REPAIR MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American soft tissue repair market during forecast period
9.2.3 CANADA
9.2.3.1 High healthcare expenditure and favorable public & private funding to support market growth
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth
9.3.3 FRANCE
9.3.3.1 Well-established healthcare system and high geriatric population to boost market growth
9.3.4 UK
9.3.4.1 Increasing hernia repair and cardiovascular surgeries to stimulate market growth
9.3.5 ITALY
9.3.5.1 Favorable government initiatives and high demand for surgical interventions to support market growth
9.3.6 SPAIN
9.3.6.1 Increasing healthcare budget and rising focus on local medical product manufacturing to drive market
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.2.1 Strong healthcare system and high geriatric population to favor market growth
9.4.3 CHINA
9.4.3.1 Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth
9.4.4 INDIA
9.4.4.1 Greater healthcare awareness and increased government support to aid market growth
9.4.5 AUSTRALIA
9.4.5.1 Increasing government support and rising healthcare expenditure to support market growth
9.4.6 SOUTH KOREA
9.4.6.1 Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Strong public healthcare system and favorable government-led initiatives to aid market growth
9.5.3 MEXICO
9.5.3.1 Increased focus on healthcare modernization and surgical innovation to favor market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.7 GCC COUNTRIES
9.7.1 FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
10.3 REVENUE ANALYSIS, 2020–2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Application footprint
10.5.5.5 End-user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of startups/SMEs
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 R&D EXPENDITURE
10.9 BRAND/PRODUCT COMPARISON
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES
10.10.2 DEALS
10.10.3 EXPANSIONS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 ARTHREX, INC.
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 MnM view
11.1.1.3.1 Right to win
11.1.1.3.2 Strategic choices
11.1.1.3.3 Weaknesses & competitive threats
11.1.2 SMITH & NEPHEW PLC
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches
11.1.2.3.2 Deals
11.1.2.3.3 Expansions
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 JOHNSON & JOHNSON SERVICES, INC.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 BECTON, DICKINSON AND COMPANY (BD)
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 MnM view
11.1.4.3.1 Right to win
11.1.4.3.2 Strategic choices
11.1.4.3.3 Weaknesses & competitive threats
11.1.5 STRYKER
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 MnM view
11.1.5.3.1 Right to win
11.1.5.3.2 Strategic choices
11.1.5.3.3 Weaknesses & competitive threats
11.1.6 MEDTRONIC
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.6.3.2 Expansions
11.1.6.3.3 Other developments
11.1.7 ZIMMER BIOMET
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Deals
11.1.8 INTEGRA LIFESCIENCES CORPORATION
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 ARTIVION, INC.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 ORGANOGENESIS INC.
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 LIFENET HEALTH
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 BAXTER
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.13 TISSUE REGENIX
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.14 CONMED CORPORATION
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.15 MERIL LIFE SCIENCES PVT. LTD.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.16 RTI SURGICAL
11.1.16.1 Business overview
11.1.16.2 Products offered
11.2 OTHER PLAYERS
11.2.1 SAMYANG HOLDINGS CORPORATION
11.2.2 AROA BIOSURGERY LIMITED
11.2.3 ACERA SURGICAL INC.
11.2.4 ORTHOCELL LTD.
11.2.5 ACELL, INC.
11.2.6 BIOCER ENTWICKLUNGS-GMBH
11.2.7 ISTO BIOLOGICS
11.2.8 BETATECH MEDICAL
11.2.9 MIMEDX GROUP, INC.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS
TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS
TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD)
TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM
TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024 (USD)
TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024 (USD)
TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS
TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES
TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS
TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 67 US: KEY MACROINDICATORS
TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 74 CANADA: KEY MACROINDICATORS
TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 88 GERMANY: KEY MACROINDICATORS
TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 95 FRANCE: KEY MACROINDICATORS
TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 102 UK: KEY MACROINDICATORS
TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 109 ITALY: KEY MACROINDICATORS
TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 116 SPAIN: KEY MACROINDICATORS
TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 136 JAPAN: KEY MACROINDICATORS
TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 143 CHINA: KEY MACROINDICATORS
TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 150 INDIA: KEY MACROINDICATORS
TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 157 AUSTRALIA: KEY MACROINDICATORS
TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 164 SOUTH KOREA: KEY MACROINDICATORS
TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 184 BRAZIL: KEY MACROINDICATORS
TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 191 MEXICO: KEY MACROINDICATORS
TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION
TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT
TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT
TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT
TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT
TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025
TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022–APRIL 2025
TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025
TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW
TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED
TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW
TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED
TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025
TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022–APRIL 2025
TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022–APRIL 2025
TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–APRIL 2025
TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
TABLE 239 STRYKER: COMPANY OVERVIEW
TABLE 240 STRYKER: PRODUCTS OFFERED
TABLE 241 MEDTRONIC: COMPANY OVERVIEW
TABLE 242 MEDTRONIC: PRODUCTS OFFERED
TABLE 243 MEDTRONIC: DEALS, JANUARY 2022–APRIL 2025
TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022–APRIL 2025
TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022–APRIL 2025
TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW
TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED
TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025
TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW
TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED
TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW
TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED
TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW
TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED
TABLE 257 BAXTER: COMPANY OVERVIEW
TABLE 258 BAXTER: PRODUCTS OFFERED
TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW
TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED
TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW
TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
TABLE 265 RTI SURGICAL: COMPANY OVERVIEW
TABLE 266 RTI SURGICAL: PRODUCTS OFFERED
TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW
TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW
TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW
TABLE 271 ACELL, INC.: COMPANY OVERVIEW
TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW
TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW
TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW
TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW
TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS
TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS
TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD)
TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM
TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024 (USD)
TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024 (USD)
TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS
TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES
TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS
TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 67 US: KEY MACROINDICATORS
TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 74 CANADA: KEY MACROINDICATORS
TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 88 GERMANY: KEY MACROINDICATORS
TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 95 FRANCE: KEY MACROINDICATORS
TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 102 UK: KEY MACROINDICATORS
TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 109 ITALY: KEY MACROINDICATORS
TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 116 SPAIN: KEY MACROINDICATORS
TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 136 JAPAN: KEY MACROINDICATORS
TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 143 CHINA: KEY MACROINDICATORS
TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 150 INDIA: KEY MACROINDICATORS
TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 157 AUSTRALIA: KEY MACROINDICATORS
TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 164 SOUTH KOREA: KEY MACROINDICATORS
TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 184 BRAZIL: KEY MACROINDICATORS
TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 191 MEXICO: KEY MACROINDICATORS
TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION
TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT
TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT
TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT
TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT
TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025
TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022–APRIL 2025
TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025
TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW
TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED
TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW
TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED
TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025
TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022–APRIL 2025
TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022–APRIL 2025
TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–APRIL 2025
TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
TABLE 239 STRYKER: COMPANY OVERVIEW
TABLE 240 STRYKER: PRODUCTS OFFERED
TABLE 241 MEDTRONIC: COMPANY OVERVIEW
TABLE 242 MEDTRONIC: PRODUCTS OFFERED
TABLE 243 MEDTRONIC: DEALS, JANUARY 2022–APRIL 2025
TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022–APRIL 2025
TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022–APRIL 2025
TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW
TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED
TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025
TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW
TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED
TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW
TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED
TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW
TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED
TABLE 257 BAXTER: COMPANY OVERVIEW
TABLE 258 BAXTER: PRODUCTS OFFERED
TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW
TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED
TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW
TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
TABLE 265 RTI SURGICAL: COMPANY OVERVIEW
TABLE 266 RTI SURGICAL: PRODUCTS OFFERED
TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW
TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW
TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW
TABLE 271 ACELL, INC.: COMPANY OVERVIEW
TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW
TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW
TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW
TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW
The soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a healthy CAGR of 7.5% from 2014 to 2019.
Growth in this market is attributed to the increasing incidence of soft tissue injuries, increasing healthcare expenditure, lack of substitutes for soft tissue repair surgery, increasing aging population & obesity rate, and geographic expansion by leading players in emerging markets.
The global soft tissue repair market is segmented by product, application, and region. This report also discusses key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products, is segmented into tissue patches/meshes, soft tissue fixation devices, and laparoscopic instruments.
Key players in Soft Tissue Repair Market are LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).
North America, a major market for global soft tissue repair, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive market growth owing to rising investments by public and private players to provide improved healthcare services in these countries, the presence of a large patient population, and the focus of leading players on capturing growth opportunities in these markets.
